Article
Optimized cell culture conditions promote <i>ex-vivo</i> manipulation and expansion of primitive hematopoietic stem cells for therapeutic gene editing
2022-01-11
Abstract excerpt
During the last few years, gene editing has emerged as a powerful tool for the therapeutic correction of monogenic diseases. CRISPR/Cas9 applied to hematopoietic stem and progenitor cells (HSPCs) has shown great promise in proof-of-principle preclinical studies to treat haematological disorders, and clinical trials using these tools are now underway. Nonetheless, there remain important challenges that need to be a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b66ce3e1-0d2e-50f1-b9b8-fa0d4695d98a
- DOI
- 10.1101/2022.01.11.475795
